OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
August 02, 2021
Advances in technology are accelerating the development and manufacture of subunit vaccines, an established class of vaccines.
June 02, 2021
Contract manufacturers play a key role in the production of lipid nanoparticles for RNA vaccines.
April 22, 2021
DFE’s new line will offer market purity and low endotoxin excipients for use in formulation, while providing drug developers and manufacturers high-quality excipient technology and services.
February 25, 2021
The company will join the network of approved manufacturers of the lipid excipients.
December 16, 2020
A newly developed polymer, DynaShield, may have the capability to ensure global access for COVID-19 treatment and prevention.
December 10, 2020
With the acquisition, Evonik will expand its life science division and its portfolio of functional excipients and biomaterials.
November 04, 2020
At the 2020 Bio/Pharma Virtual Congress, experts discuss the importance of characterizing excipients to ensure quality, safety, and effective performance.
June 04, 2020
CordenPharma announces expansion of lipid excipients supply for coronavirus vaccine scale up.
March 19, 2020
USP technical advisors will offer assistance to drug developers to ensure material quality and testing.
February 13, 2020
The companies have entered into a global licensing and collaboration agreement to commercialize ReForm excipients used in biotherapeutic formulations.